Nav: Home

The ever-changing brain: Shining a light on synaptic plasticity

November 20, 2019

Synapses - specialized structures in neurons - allow these nerve cells to communicate with one another. In the synapse, one neuron emits chemical messengers called neurotransmitters, and an apposed neuron receives them using tiny structures called receptors.

A specific type of receptor, the AMPA receptor, plays a crucial role in learning and memory processes. However, scientists don't yet fully understand how these AMPA receptors form and work.

Now, researchers in the Membrane Cooperativity Unit at the Okinawa Institute of Science and Technology Graduate University (OIST) in Japan, in collaboration with researchers from universities across Japan, have found that AMPA receptors form and disintegrate continually, within a fraction of a second, rather than existing as stable entities. The scientists' findings, published in Nature Communications, may help clarify early stages of synaptic plasticity: neural activity that is key for learning and memory. The research may also have pharmacological applications in the treatment of epilepsy.

The changing brain

AMPA receptors are composed of four molecules, or subunits - called GluA1, 2, 3, and 4 - which unite to form structures called tetramers. Different combinations of the subunits form the tetramers; this means there are 256 possible configurations of AMPA receptor.

Scientists have long believed that these tetramers originate in the endoplasmic reticulum, the cell's "manufacturing center," before migrating to the synapses, all while retaining stable structures for hours or even days.

"This tetramer stability could actually be problematic for neurons," said Professor Akihiro Kusumi, a co-author of the study. "The synapses need AMPA receptor tetramers with different combinations of subunits as the brain learns and its neuronal circuits change. Thus, we had a gut feeling that something was terribly wrong with the accepted notion of how AMPA receptors form, migrate, and work."

Looking at AMPA receptors in motion at single-molecule resolutions

Following this intuition, the researchers put fluorescent tags on each individual subunit molecule of the AMPA receptors. Then, they tracked the molecules' movements in live cells at nanometer-precisions. They used a single-molecule fluorescence microscope and software to analyze the motion of the single molecules, a method Kusumi and his colleagues pioneered.

By studying how the AMPA receptor molecules jostled around in the membrane and bound to each other, the researchers found that the AMPA receptor subunits existed as single molecules as well as assemblies two, three, and four molecules.

Tetramers were found, but they fell apart in about 0.1 to 0.2 seconds. Then, however, the separated molecules found other partner molecules to form new assemblies of two, three, and four molecules again, continually repeating this process.

In addition, the researchers found that when the molecules formed tetramers, albeit briefly, they worked as tiny channels that opened for less than 0.1 seconds.

Since the functional tetramers are continually broken up to form new tetramers, AMPA receptor tetramers with different subunit compositions can readily be formed. This represents a novel mechanism for synaptic plasticity.

Kusumi noted that the team's findings may have medical applications. Individuals with epilepsy have an excess of glutamate, the neurotransmitter that binds to AMPA receptors in the brain. These individuals are often treated with anticonvulsants that stop glutamate from binding to AMPA receptor tetramers, but these treatments can be too overpowering, and therefore ineffective.

Kusumi believes the development of drugs that slow down the formation of tetramers with certain subunit compositions in the brain could mitigate problematic types of synaptic plasticity, thus diminishing the symptoms of epilepsy.
-end-


Okinawa Institute of Science and Technology (OIST) Graduate University

Related Epilepsy Articles:

Antibodies in the brain trigger epilepsy
Certain forms of epilepsy are accompanied by inflammation of important brain regions.
Breaching the brain's defense causes epilepsy
Epileptic seizures can happen to anyone. But how do they occur and what initiates such a rapid response?
Using connectomics to understand epilepsy
Abnormalities in structural brain networks and how brain regions communicate may underlie a variety of disorders, including epilepsy, which is one focus of a two-part Special Issue on the Brain Connectome in Brain Connectivity, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Epilepsy: Triangular relationship in the brain
When an epileptic seizure occurs in the brain, the nerve cells lose their usual pattern and fire in a very fast rhythm.
How concussions may lead to epilepsy
Researchers have identified a cellular response to repeated concussions that may contribute to seizures in mice like those observed following traumatic brain injury in humans.
Understanding epilepsy in pediatric tumors
A KAIST research team led by Professor Jeong Ho Lee of the Graduate School of Medical Science and Engineering has recently identified a neuronal BRAF somatic mutation that causes intrinsic epileptogenicity in pediatric brain tumors.
Can medical marijuana help treat intractable epilepsy?
A new British Journal of Clinical Pharmacology review examines the potential of medicinal cannabis -- or medical marijuana -- for helping patients with intractable epilepsy, in which seizures fail to come under control with standard anticonvulsant treatment.
Fertility rates no different for women with epilepsy
'Myth-busting' study among women with no history of infertility finds that those with epilepsy are just as likely to become pregnant as those without.
Do women with epilepsy have similar likelihood of pregnancy?
Women with epilepsy without a history of infertility or related disorders who wanted to become pregnant were about as likely as their peers without epilepsy to become pregnant.
Hope for new treatment of severe epilepsy
Researchers at Lund University in Sweden believe they have found a method that in the future could help people suffering from epilepsy so severe that all current treatment is ineffective.
More Epilepsy News and Epilepsy Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.